User profiles for "author:Macy Tong"

Macy Tong

Clinical Associated Professor (Hon), Dept of Clinical Oncology, The Chinese University of …
Verified email at cuhk.edu.hk
Cited by 924

Analysis of plasma Epstein-Barr virus DNA in nasopharyngeal cancer after chemoradiation to identify high-risk patients for adjuvant chemotherapy: a randomized …

ATC Chan, EP Hui, RKC Ngan, SY Tung… - Journal of clinical …, 2018 - ascopubs.org
Purpose The contribution of adjuvant chemotherapy after chemoradiation therapy (CRT) in
nasopharyngeal cancer (NPC) remains controversial. Plasma Epstein-Barr virus (EBV) DNA …

Induction chemotherapy plus concurrent chemoradiotherapy in endemic nasopharyngeal carcinoma: individual patient data pooled analysis of four randomized trials

YP Chen, LL Tang, Q Yang, SS Poh, EP Hui… - Clinical Cancer …, 2018 - AACR
Purpose: Because of the uneven geographic distribution and small number of randomized
trials available, the value of additional induction chemotherapy (IC) to concurrent …

Extranodal extension is a criterion for poor outcome in patients with metastatic nodes from cancer of the nasopharynx

QY Ai, AD King, DMC Poon, FKF Mo, EP Hui, M Tong… - Oral Oncology, 2019 - Elsevier
Purpose Extranodal extension (ENE) is a criterion for advanced nodal staging of
oropharyngeal and hypopharyngeal carcinoma. Our aim was to determine if ENE should be …

[HTML][HTML] A randomized study of olanzapine-containing versus standard antiemetic regimens for the prevention of chemotherapy-induced nausea and vomiting in …

W Yeo, TKH Lau, L Li, KT Lai, E Pang, M Cheung… - The Breast, 2020 - Elsevier
Objectives Chemotherapy-induced nausea and vomiting (CINV) are distressing symptoms.
This randomized study evaluated the antiemetic efficacies of standard antiemetic regimen …

Integrative palliative care service model improved end-of-life care and overall survival of advanced cancer patients in Hong Kong: A review of ten-year territory-wide …

TC Lam, SK Chan, CW Choi, KC Tsang… - Journal of Palliative …, 2021 - liebertpub.com
Background: Integrated palliative care in oncology service has been widely implemented in
Hong Kong since 2006. Aim: The study aimed to review its impact on end-of-life outcomes …

Pre-treatment amide proton transfer imaging predicts treatment outcome in nasopharyngeal carcinoma

S Qamar, AD King, QYH Ai, FKF Mo, W Chen… - European …, 2020 - Springer
Objective To investigate the value of pre-treatment amide proton transfer–weighted (APTw)
imaging for predicting survival of patients with nasopharyngeal carcinoma (NPC). Materials …

Dynamic changes of post-radiotherapy plasma Epstein–Barr virus DNA in a randomized trial of adjuvant chemotherapy versus observation in nasopharyngeal cancer

EP Hui, BBY Ma, WKJ Lam, KCA Chan, F Mo… - Clinical Cancer …, 2021 - AACR
Purpose: To study the dynamic changes in plasma Epstein–Barr virus (pEBV) DNA after
radiotherapy in nasopharyngeal cancer (NPC). Experimental Design: We conducted a …

Pre-treatment intravoxel incoherent motion diffusion-weighted imaging predicts treatment outcome in nasopharyngeal carcinoma

S Qamar, AD King, QYH Ai, TY So, FKF Mo… - European Journal of …, 2020 - Elsevier
Purpose To evaluate whether pre-treatment intravoxel incoherent motion diffusion-weighted
imaging (IVIM-DWI) can predict treatment outcome after 2 years in patients with …

Second primary cancer after intensity-modulated radiotherapy for nasopharyngeal carcinoma: a territory-wide study by HKNPCSG

JCH Chow, AHP Tam, KM Cheung, VHF Lee… - Oral Oncology, 2020 - Elsevier
Objectives Long-term risk of second primary cancer (SPC) after definitive intensity-
modulated radiotherapy (IMRT) for nasopharyngeal carcinoma (NPC) remains unclear. This …

Induction chemotherapy with cisplatin and gemcitabine followed by accelerated radiotherapy and concurrent cisplatin in patients with stage IV (A‐B) nasopharyngeal …

TK Yau, AWM Lee, DHM Wong, RMW Yeung… - Head & …, 2006 - Wiley Online Library
Background. The purpose of this study was to evaluate the efficacy and toxicity of cisplatin
plus gemcitabine as induction chemotherapy in advanced nasopharyngeal carcinoma …